Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion type Assertion NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_head.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion description "[Adel55-cHSF1 treatment also showed higher efficacy in diminishing progression of the secondary tumor focus than Adel55-HSP70 or Adel55-HSP90 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion evidence source_evidence_literature NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion SIO_000772 22613625 NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion wasDerivedFrom befree-20140225 NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion wasGeneratedBy ECO_0000203 NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.